Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject

This study has been completed.
Sponsor:
Information provided by:
Otsuka Beijing Research Institute
ClinicalTrials.gov Identifier:
NCT00823875
First received: January 15, 2009
Last updated: November 30, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2010
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)